SLS - Sellas falls 17% amid Phase 3 study update for galinpepimut-S
2024-06-17 15:07:56 ET
More on SELLAS Life Sciences
- Sellas Life Sciences Group: A Lottery Ticket With An Estimated 6x Payout
- Solaris Resources announces $35 million bought deal offering
- Sellas reports positive Phase 2 data from AML study, files for patent
- Seeking Alpha’s Quant Rating on SELLAS Life Sciences
- Historical earnings data for SELLAS Life Sciences